¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Multiple Sclerosis, Relapsing-Remitting"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • endocardial sclerosis
    ½É³»¸·°æÈ­Áõ
  • focal glomerular sclerosis
    ±¹¼ÒÅ丮±»À½Áõ, ±¹¼Ò»ç±¸Ã¼°æÈ­Áõ
  • funicular sclerosis
    ¼¶À¯´Ü°æÈ­
  • hippocampal sclerosis
    ÇØ¸¶°æÈ­(Áõ)
  • insular sclerosis
    ¼¶°æÈ­Áõ
  • lobar sclerosis
    ¿±¼º°æÈ­Áõ
  • medial calcific sclerosis
    Á߸·¼®È¸È­°æÈ­Áõ
  • nodular sclerosis
    °áÀý°æÈ­
  • nuclear sclerosis
    ¼öÁ¤Ã¼ÇÙ°æÈ­
  • posterior spinal sclerosis
    µÚô¼ö°æÈ­Áõ, ô¼öÈÄ»è°æÈ­Áõ
  • posterolateral sclerosis
    ÈÄ»èÃø»è°æÈ­Áõ, ¾Æ±Þ¼º¿¬ÇÕº¯¼º
  • presenile sclerosis
    ÃʷΰæÈ­Áõ
  • primary lateral sclerosis
    ¿ø¹ß°¡ÂʰæÈ­Áõ, ¿ø¹ßÃø»è°æÈ­Áõ
  • progressive systemic sclerosis
    ÁøÇàÀü½Å°æÈ­Áõ
  • perigenital sclerosis
    »ý½Ä±âÁÖÀ§°æÈ­(Áõ)
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • endocardial sclerosis
    ½ÉÀå³»¸·°æÈ­Áõ
  • focal glomerular sclerosis
    ±¹¼ÒÅ丮±»À½Áõ, ±¹¼Ò»ç±¸Ã¼°æÈ­Áõ
  • funicular sclerosis
    ¼¶À¯´Ü°æÈ­(Áõ)
  • hippocampal sclerosis
    ÇØ¸¶°æÈ­Áõ
  • insular sclerosis
    (¢¡multiple sclerosis) ´Ù¹ß°æÈ­Áõ
  • lobar sclerosis
    ¿±°æÈ­Áõ
  • medial calcific sclerosis
    Á߸·¼®È¸È­°æÈ­Áõ
  • nodular sclerosis
    °áÀý°æÈ­Áõ
  • nuclear sclerosis
    ¼öÁ¤Ã¼ÇÙ°æÈ­
  • perigenital sclerosis
    »ý½Ä±âÁÖÀ§°æÈ­Áõ
  • posterior spinal sclerosis
    µÚô¼ö°æÈ­Áõ
  • posterolateral sclerosis
    (¢¡subacute combined degeneration) ¾Æ±Þ¼º¿¬ÇÕº¯¼º
  • presenile sclerosis
    ÃʷΰæÈ­(Áõ)
  • primary lateral sclerosis
    ¿ø¹ß°¡ÂʰæÈ­Áõ
  • progressive systemic sclerosis
    (¢¡systemic scleroderma) Àü½ÅÇǺΰæÈ­Áõ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • hepatoportal sclerosis
    °£¹®¸Æ°æÈ­Áõ.
  • hereditary cerebellar sclerosis
    À¯Àü¼º ¼Ò³ú°æÈ­Áõ.
  • hereditary spinal sclerosis
    À¯Àü¼º ô¼ö °æÈ­Áõ(¡­Ìãûùñø).
  • hereditary spinal sclerosis
    À¯Àü¼º ô¼ö°æÈ­Áõ(¡­Ìãûùñø).
  • hodgkins disease,nodular sclerosis
    °áÀý¼º °æÈ­¼º
  • pigmentary sclerosis
    »ö¼Ò°æÈ­Áõ(ßäáÈàõ)
  • posterior spinal sclerosis
    ÈÄô¼ö°æÈ­Áõ (¡­Ìãûùñø).
  • posterior spinal sclerosis
    ÈÄô¼ö°æÈ­Áõ(ý­ô±âÐÌãûùñø)
  • posterolateral sclerosis
    ÈÄ»èÃø»è°æÈ­Áõ.
  • posterolateral sclerosis
    ÈÄ»èÃø»è°æÈ­Áõ(ÈÄ»èÃø»èÌãûùñø)
  • posterolateral sclerosis syndrome
    ÈÄ»èÃø»è°æÈ­ÁõÁõÈıº.
  • presenile sclerosis
    Ãʷμº °æÈ­(Áõ) (¡­Ìãûùñø).
  • presenile sclerosis
    Ãʷμº °æÈ­(Áõ)(ôøÖÕàõ Ìãûùñø)
  • primary lateral sclerosis
    ¿ø¹ß(¼º) Ãø»è°æÈ­(Áõ)(¡­ö°ßãÌãûùñø).
  • primary lateral sclerosis
    ¿ø¹ß(¼º) Ãø»è°æÈ­(Áõ)(ê«Û¡(àõ) ö°ßãÌãûùñø)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • calcific sclerosis
    ¼®È¸È­°æÈ­Áõ(¡­Ìãûùñø)
  • cardiac sclerosis
    ½ÉÀμº °æÈ­Áõ (ãýì×àõÌãûùñø)
  • cardiac sclerosis,hepatic
    °£ °æÈ­Áõ(ÊÜÌãûùñø)
  • choroidal sclerosis
    ¸Æ¶ô¸·°æÈ­(Áõ)
  • combined sclerosis
    º´ÇÕ°æÈ­Áõ(ܱùê Ìãûùñø).
  • coronary sclerosis
    °ü(»ó)(µ¿¸Æ)°æÈ­Áõ(ήßÒÔÑØæÌãûùñø).
  • degenerative diffuse cerebral sclerosis
    ÅðÇ༺ ¹Ì¸¸¼º ³ú°æÈ­(Áõ)(¡­Ú¯Ø·àõ ÒàÌãûùñø).
  • diffuse cerebral sclerosis
    ¹Ì¸¸¼º ³ú°æÈ­Áõ.
  • diffuse sclerosis
    ¹ü¹ß¼º °æÈ­Áõ(ÛñÛ¡àõÌãûùñø).
  • diffuse systemic sclerosis
    ±¤¹üÀ§ Àü½Å °æÈ­Áõ
  • disseminated sclerosis
    ÆÄÁ¾¼º °æÈ­Áõ(¡­Ìãûùñø).
  • endocardial sclerosis
    ½É³»¸·°æÈ­Áõ(¡­Ìãûùñø).
  • funicular sclerosis
    »è»ó°æÈ­(Áõ).
  • hepatoportal sclerosis
    °£¹®¸Æ°æÈ­Áõ.
  • hereditary cerebellar sclerosis
    À¯Àü¼º ¼Ò³ú°æÈ­Áõ.
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • multiple polyp
    ´Ù¹ß¼ºÆú¸³
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
MS   1) Mitral Stenosis
  2) Multiple Sclerosis; ´Ù¹ß¼º °æÈ­Áõ
  3) Macro...
CPMS chronic progressive multiple sclerosis
IFMSS International Federation of Multiple Sclerosis Societies
MS Maffuci syndrome; maladjustment score; mandibular series; Marfan syndrome; Marie-Strumpell [syndrome...
MSAA multiple sclerosis-associated agent
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
DMS Diffuse mesangial sclerosis
FALS Familial Amyotrophic Lateral Sclerosis
FGS Focal glomerular sclerosis
HS Hippocampal sclerosis
LS Lichen sclerosis
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • subchondral sclerosis
    ¿¬°ñÇÏ °æÈ­Áõ
  • subepithelial deposit and sclerosis
    »óÇÇÇÏ ÃàÀû°ú °æÈ­
  • systemic sclerosis
    Àü½Å¼º °æÈ­Áõ, °øÇÇÁõ. °æÇÇÁõ
    ÇǺÎ, ½ÉÀå, ½Äµµ, ½ÅÀå ¹× Æó¸¦ Æ÷ÇÔÇÑ ½Åü ¸ðµç ºÎÀ§ °áÇÕ Á¶Á÷ÀÇ ¸¸¼ºÀûÀÎ °æÈ­ ¹× À§Ãà. ÇǺδ ºñÈÄ, °æÈ­, °­Á÷µÇ°í Âø»öµÈ ¹ÝÀÌ »ý±ä´Ù. À̰ÍÀº Àü½Å¼ºÀÎ °æ¿ì »çÁöÀÇ ¸»´ÜºÎ³ª ¾ó±¼ ¶Ç´Â ¼Õ°¡¶ô¿¡ ±¹ÇÑµÈ °æ¿ì, EH´Â Á÷°æ ¼ö cmÀÇ l ³­Çü ¶Ç´Â ¼±»ó ¿µ¿ª¿¡ ±¹ÇÑ µÈ °æ¿ì°¡ ÀÖ´Ù.
  • tuberous sclerosis
    °áÀý¼º °æÈ­Áõ
    »ó¿°»öü ¿ì¼º À¯ÀüÀ» ÇÏ´Â º¹ÇÕÀûÀÎ ½Å°æ ÇǺΠÁõÈıºÀ¸·Î °£Áú, Á¤½Å ¹Ú¾à ¹× Ç÷°ü ¼¶À¯Á¾°ú »þ±×¸° ¹Ý
  • tuberous sclerosis
    °áÀý¼º °æÈ­Áõ
  • vascular sclerosis
    Ç÷°ü °æÈ­
  • affecting multiple system
    ´Ù¹ß¼º °èÅëÀ» ħ¹üÇÑ
  • discrete multiple endocrine adenomatosis syndrome
    ºÐ¸®¼º ´Ù¹ß ³»ºÐºñ ¼±Á¾ ÁõÈıº
  • multiple
    ´Ù¹ß¼º, ´Ù¼öÀÇ
  • multiple abutment
    ´Ù¼ö Áö´ëÄ¡
  • multiple allelomorph
    º¹´ë¸³ À¯ÀüÀÚ
  • multiple anchorage
    º¹ÇÕ °íÁ¤
    1Çü½Ä ÀÌ»óÀÇ ÈûÀ» °¡ÇÏ´Â ÀåÄ¡¸¦ »ç¿ëÇÏ´Â °íÁ¤.
  • multiple angioma
    ´Ù¹ß¼º ¸Æ°üÁ¾
  • multiple biologically active peptide fragment
    ´Ù¹ß¼º »ý¹°ÇÐÀû Ȱ¼º ÆéŸÀÌµå ºÐÀý
  • multiple cavernous hemangioma
    ´Ù¹ß¼º ÇØ¸é Ç÷°üÁ¾
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
cerebral sclerosis, diffuse Diffuse progressive degeneration of the white matter of the brain, accompanied by mental deterioration, severe motor disturbances, and early death.
(12 Dec 1998)
menstrual sclerosis A slowly progressive sclerosis in the walls of the ovarian arteries which commences after puberty.
Synonym: menstrual sclerosis, ovulational sclerosis.
(05 Mar 2000)
physiologic sclerosis A slowly progressive sclerosis in the walls of the ovarian arteries which commences after puberty.
Synonym: menstrual sclerosis, ovulational sclerosis.
(05 Mar 2000)
Monckeberg's sclerosis Arterial sclerosis involving the peripheral arteries, especially of the legs of older people, with deposition of calcium in the medial coat (pipestem arteries) but with little or no encroachment on the lumen.
Synonym: medial arteriosclerosis, Monckeberg's calcification, Monckeberg's degeneration, Monckeberg's medial calcification, Monckeberg's sclerosis.
(05 Mar 2000)
combined sclerosis A subacute or chronic disorder of the spinal cord, such as that occurring in certain patients with vitamin B12 deficiency, characterised by a slight to moderate degree of gliosis in association with spongiform degeneration of the posterior and lateral columns.
Synonym: combined sclerosis, combined system disease, funicular myelitis, Putnam-Dana syndrome, vitamin B12 neuropathy.
(05 Mar 2000)
posterior sclerosis See Tabes dorsalis.
(12 Dec 1998)
posterior spinal sclerosis See Tabes dorsalis.
(12 Dec 1998)
primary lateral sclerosis Considered by many to be a subgroup of motor neuron disease; a slowly progressive degenerative disorder of the motor neurons of the cerebral cortex, resulting in widespread weakness on an upper motor neuron basis; spasticity, hyperreflexia, and Babinski signs are present, but not fasciculation potentials, nor any electrodiagnostic evidence of a lower motor neuron lesion.
Synonym: lateral spinal sclerosis.
(05 Mar 2000)
sclerosis <pathology> A induration or hardening, especially hardening of a part from inflammation and in diseases of the interstitial substance. The term is used chiefly for such a hardening of the nervous system due to hyperplasia of the connective tissue or to designate hardening of the blood vessels.
Origin: Gr. Sklerosis = hardness
(18 Nov 1997)
sclerosis corii <dermatology> Hardening of skin.
(04 Mar 1998)
sclerosis cutanea Synonym: scleroderma.
(05 Mar 2000)
sclerosis of white matter <radiology> Type of dysmyelinating disease, hereditary, peripheral nervous system unaffected in some disorders Specific diseases: adrenoleukodystrophy, metachromatic leukodystrophy, spongy degeneration (Canavan), globoid cell (Krabbe) leukodystrophy, Alexander disease, Pelizaeus-Merzbacher disease, Cockayne syndrome
(12 Dec 1998)
hippocampal sclerosis A loss of cortical neurons and a reactive astrocytosis in the hippocampal regions of some persons with epilepsy.
(05 Mar 2000)
skin lesions of tuberous sclerosis <radiology> Adenoma sebaceum, Shagreen patches, periungual fibromata, ash-leaf hypopigmentation
(12 Dec 1998)
nodular sclerosis <cardiology, pathology> The progressive narrowing and hardening of the arteries over time.
This is known to occur to some degree with aging, but other risk factors that accelerate this process have been identified.
These factors include: high cholesterol, high blood pressure, smoking, diabetes and family history for atherosclerotic disease.
(27 Sep 1997)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á